Navigation Links
Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations
Date:9/4/2008

Practice Bulletin for Obstetrician-Gynecologists States UFE Meets Level A Evidence for Clinical Practice Change-Minimally Invasive Interventional Radiology Treatment Is Safe, Effective Option for Women With Uterine Fibroids

FAIRFAX, Va., Sept. 4 /PRNewswire-USNewswire/ -- The Society of Interventional Radiology, a national organization of nearly 4,500 doctors, scientists and allied health professionals dedicated to improving health care through minimally invasive treatment interventions, applauds the recommendations of the American College of Obstetricians and Gynecologists that uterine fibroid embolization "is a safe and effective option" for women. "This finding fully opens the door to women's choice. It will prompt gynecologists to discuss all treatment options for symptomatic uterine fibroids--including UFE--if they are not already doing so," said interventional radiologist John Kaufman, M.D., SIR president.

In its August practice bulletin, "Alternatives to Hysterectomy in the Management of Leiomyomas," ACOG listed UFE among Level A treatment options, meaning that the minimally invasive treatment is considered safe and effective based on long- and short-term outcomes data. Level A evidence is the highest grade possible. The ACOG practice bulletin is used by doctors to aid in making decisions about appropriate patient care. "This is especially significant news for the 200,000 women who have hysterectomies performed annually in the United States to treat symptomatic uterine fibroids. Many of these women can confidently choose UFE," noted Kaufman.

"Women seeking treatment for their fibroids should be aware of all of their treatment options. UFE may be one of those options, and the best way to determine this is to for the woman and her gynecologist to consult with an interventional radiologist," said Kaufman. "The procedure is widely available, and finding an interventional radiologist who performs UFE is easy. The online SIR physician directory specifically identifies interventional radiologists with expertise in this area," he added. Interventional radiologists often use imaging tests such as MRI to help determine whether a woman is a candidate for UFE. Sometimes additional important information about the pelvic organs is found that helps the woman choose her best treatment option.

Uterine fibroids are benign tumors that can cause prolonged, heavy menstrual bleeding that can be severe enough to cause anemia or require transfusion; disabling pelvic pain and pressure; urinary frequency; pain during intercourse; and miscarriage. Twenty to 40 percent of women age 35 and older have uterine fibroids of a significant size; African-American women are at a higher risk for fibroids (as many as 50 percent have fibroids of a significant size).

Pioneered and performed by interventional radiologists, UFE blocks tiny blood vessels that feed fibroids, causing the tumor to die and symptoms to subside. An interventional radiologist uses imaging to guide a thin catheter to the uterine artery to treat the source of the disease internally, avoiding open surgery. The procedure offers less risk, less pain and a shorter recovery time compared to open surgery.

The ACOG practice bulletin notes, "Based on long- and short-term outcomes, uterine artery embolization (UAE) is a safe and effective option for appropriately selected women who wish to retain their uteri." It compares UAE, also referred to as UFE, to other treatment methods and favorably points out the large amount of peer-reviewed literature illustrating its effectiveness. It indicates that women who want to choose UFE "should have a thorough evaluation with an obstetrician-gynecologist to help facilitate optimal collaboration with the interventional radiologist and to ensure the appropriateness of therapy, taking into account the reproductive wishes of the patient."

About the Society of Interventional Radiology

Interventional radiologists are physicians who specialize in minimally invasive, targeted treatments. They offer the most in-depth knowledge of the least invasive treatments available coupled with diagnostic and clinical experience across all specialties. They use X-ray, MRI and other imaging to advance a catheter in the body, usually in an artery, to treat at the source of the disease internally. As the inventors of angioplasty and the catheter-delivered stent, which were first used in the legs to treat peripheral arterial disease, interventional radiologists pioneered minimally invasive modern medicine.

Today, interventional radiology treatments are first-line care for many conditions that once required surgery. Interventional radiology treatments generally offer less risk, less pain and less recovery time compared to open surgery. In 2008, the Society of Interventional Radiology (SIR) celebrates 35 years of quality patient care innovation. Visit http://www.SIRweb.org.


'/>"/>
SOURCE Society of Interventional Radiology
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology
2. Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
3. TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet
4. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008
5. Landmark HIV/AIDS Publication Launches at International AIDS Society Conference in Mexico City
6. Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents
7. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
8. Data Presented at American Headache Societys Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics Tezampanel
9. MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting
10. Headache Specialists Convene in Boston For 50th Annual American Headache Society Meeting
11. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016   Bay Area Lyme Foundation ... Dean Center for Tick Borne Illness , Harvard ... MIT Hacking Medicine, University of California, Berkeley, and ... the five finalists of Lyme Innovation , ... than 100 scientists, clinicians, researchers, entrepreneurs, and investors ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American Respiratory ... testing company, is now able to perform sophisticated lung assessments in ... Medical Technologies , Inc. Patients are no longer ... to ndd,s EasyOne PRO ® , ARL patients like Jeanne R. ... testing done in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):